Study identifies three novel broad-spectrum SARS-CoV-2 cell entry inhibitors

[News]

Researchers from the National Institutes of Health (NIH) and Cornell University in the U.S. just described several new inhibitors of human coronavirus spike proteins by screening a library of approved drugs with SARS-S and MERS-S pseudotyped particle entry assays. Their exciting findings are currently available on the bioRxiv preprint server.

More... (https://www.news-medical.net/news/20200713/Study-identifies-three-novel-broad-spectrum-SARS-CoV-2-cell-entry-inhibitors.aspx)